PL1499278T3 - Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon - Google Patents
Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolonInfo
- Publication number
- PL1499278T3 PL1499278T3 PL04737220T PL04737220T PL1499278T3 PL 1499278 T3 PL1499278 T3 PL 1499278T3 PL 04737220 T PL04737220 T PL 04737220T PL 04737220 T PL04737220 T PL 04737220T PL 1499278 T3 PL1499278 T3 PL 1499278T3
- Authority
- PL
- Poland
- Prior art keywords
- dosage form
- immediate
- pharmaceutical dosage
- release pharmaceutical
- polymorphous tibolone
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 3
- WZDGZWOAQTVYBX-XOINTXKNSA-N tibolone Chemical compound C([C@@H]12)C[C@]3(C)[C@@](C#C)(O)CC[C@H]3[C@@H]1[C@H](C)CC1=C2CCC(=O)C1 WZDGZWOAQTVYBX-XOINTXKNSA-N 0.000 title abstract 3
- 229960001023 tibolone Drugs 0.000 title abstract 3
- 239000012729 immediate-release (IR) formulation Substances 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03101500 | 2003-05-23 | ||
| PCT/EP2004/050852 WO2004103378A1 (en) | 2003-05-23 | 2004-05-19 | Immediate-release pharmaceutical dosage form comprising polymorphous tibolone |
| EP04737220A EP1499278B1 (en) | 2003-05-23 | 2004-05-19 | Immediate-release pharmaceutical dosage form comprising polymorphous tibolone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1499278T3 true PL1499278T3 (pl) | 2005-09-30 |
Family
ID=33442854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04737220T PL1499278T3 (pl) | 2003-05-23 | 2004-05-19 | Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20060134191A1 (pl) |
| EP (1) | EP1499278B1 (pl) |
| JP (1) | JP2006514996A (pl) |
| KR (2) | KR20050038590A (pl) |
| AT (1) | ATE296606T1 (pl) |
| AU (1) | AU2004203420B8 (pl) |
| CA (1) | CA2473718A1 (pl) |
| DE (1) | DE602004000016T2 (pl) |
| DK (1) | DK1499278T3 (pl) |
| ES (1) | ES2243919T3 (pl) |
| MX (1) | MXPA05000824A (pl) |
| NZ (1) | NZ534446A (pl) |
| PL (1) | PL1499278T3 (pl) |
| PT (1) | PT1499278E (pl) |
| WO (1) | WO2004103378A1 (pl) |
| ZA (1) | ZA200406042B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1563833B1 (de) * | 2004-02-06 | 2006-11-02 | Helm AG | Pharmazeutische Zubereitungen mit amorphem Tibolon |
| US20100287884A1 (en) * | 2007-10-25 | 2010-11-18 | Sangita Seshadri | Powder conditioning of unit dose drug packages |
| KR101361244B1 (ko) * | 2012-02-23 | 2014-02-11 | 박현석 | 무선 메시지를 이용한 문서 전송 시스템 및 방법 |
| CN107078529A (zh) * | 2015-11-02 | 2017-08-18 | 约瑟夫·古德里奇 | 可充电式照明鞋子 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE665514A (pl) * | 1964-06-16 | |||
| FR2408345A1 (fr) * | 1976-11-30 | 1979-06-08 | Besins Jean Louis | Nouvelle composition a action anti-conceptionnelle |
| US4701450A (en) * | 1984-03-21 | 1987-10-20 | Akzo N.V. | Steroids for use as immunomodulators |
| IE63051B1 (en) * | 1989-03-18 | 1995-03-22 | Akzo Nv | Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one |
| IL123984A (en) * | 1997-04-22 | 2004-09-27 | Akzo Nobel Nv | Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable |
| US6761903B2 (en) * | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
| SK9592002A3 (en) * | 2000-01-28 | 2003-12-02 | Endorech Inc | A method for reduction or elimination of the incidence of menopausal symptoms, method of treatment or decreasing the risk of an acquiring disease, a pharmaceutical composition and a kit |
| DE60220699T2 (de) * | 2001-10-18 | 2008-03-06 | Norton Healthcare Ltd. | Tibolonformulierungen |
-
2004
- 2004-05-19 PL PL04737220T patent/PL1499278T3/pl unknown
- 2004-05-19 WO PCT/EP2004/050852 patent/WO2004103378A1/en not_active Ceased
- 2004-05-19 US US10/503,356 patent/US20060134191A1/en not_active Abandoned
- 2004-05-19 ES ES04737220T patent/ES2243919T3/es not_active Expired - Lifetime
- 2004-05-19 DK DK04737220T patent/DK1499278T3/da active
- 2004-05-19 AU AU2004203420A patent/AU2004203420B8/en not_active Expired
- 2004-05-19 KR KR1020047012310A patent/KR20050038590A/ko not_active Ceased
- 2004-05-19 PT PT04737220T patent/PT1499278E/pt unknown
- 2004-05-19 CA CA002473718A patent/CA2473718A1/en active Granted
- 2004-05-19 KR KR1020067003455A patent/KR20060028822A/ko not_active Ceased
- 2004-05-19 AT AT04737220T patent/ATE296606T1/de active IP Right Revival
- 2004-05-19 JP JP2005518190A patent/JP2006514996A/ja active Pending
- 2004-05-19 DE DE602004000016T patent/DE602004000016T2/de not_active Expired - Lifetime
- 2004-05-19 MX MXPA05000824A patent/MXPA05000824A/es active IP Right Grant
- 2004-05-19 EP EP04737220A patent/EP1499278B1/en not_active Revoked
- 2004-05-19 NZ NZ534446A patent/NZ534446A/en unknown
- 2004-07-28 ZA ZA200406042A patent/ZA200406042B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05000824A (es) | 2005-04-28 |
| KR20060028822A (ko) | 2006-04-03 |
| JP2006514996A (ja) | 2006-05-18 |
| EP1499278B1 (en) | 2005-06-01 |
| PT1499278E (pt) | 2005-08-31 |
| WO2004103378A1 (en) | 2004-12-02 |
| AU2004203420B2 (en) | 2008-01-31 |
| ES2243919T3 (es) | 2005-12-01 |
| DE602004000016D1 (de) | 2005-07-07 |
| ZA200406042B (en) | 2006-05-31 |
| DE602004000016T2 (de) | 2005-11-03 |
| EP1499278A1 (en) | 2005-01-26 |
| CA2473718A1 (en) | 2004-11-23 |
| KR20050038590A (ko) | 2005-04-27 |
| DK1499278T3 (da) | 2005-10-03 |
| NZ534446A (en) | 2007-03-30 |
| AU2004203420A1 (en) | 2004-12-02 |
| AU2004203420B8 (en) | 2008-02-21 |
| ATE296606T1 (de) | 2005-06-15 |
| US20060134191A1 (en) | 2006-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003274681A1 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
| GEP20074047B (en) | Pramipexole once-daily dosage form | |
| DK0954314T3 (da) | Doseringsformer til bedring af mandlig erektionsdefekt | |
| MY129356A (en) | Electrospun pharmaceutical compositions | |
| BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
| MX2007015480A (es) | Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada. | |
| BG108516A (en) | Pharmaceutical formulation | |
| IL165786A0 (en) | Ibuprofen suspension | |
| IL150528A0 (en) | Ibuprofen containing active agent preparation | |
| ATE287264T1 (de) | Oral anzuwendende buprenorphinhaltige arzneimittel | |
| BR0112847A (pt) | Uso de uma forma de dosagem sólida | |
| MXPA06000332A (es) | Nueva composicion farmaceutica solida que comprende amisulprida. | |
| PL1499278T3 (pl) | Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon | |
| MY130445A (en) | Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone | |
| ATE297760T1 (de) | Pharmazeutische zusammensetzungen enthaltend terbinafin | |
| PL378106A1 (pl) | Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem | |
| MY141008A (en) | Oral formulations of deoxypeganine and their uses | |
| ATE327738T1 (de) | Synergistische füllzusammensetzung | |
| WO2007119249A3 (en) | Pharmaceutical compositions of cefixime | |
| TW200621304A (en) | Pharmaceutical composition | |
| TW200621224A (en) | Pharmaceutical composition | |
| WO2005115092A3 (en) | Micronized oral pharmaceutical composition | |
| IL162769A0 (en) | Tibolone in the treatment of complaints associatedwith the administration of drugs which prevent thesynthesis of endogenousestrogen | |
| ECSP982396A (es) | Composiciones que contienen tetrahidrolipstatina | |
| HU0101360D0 (en) | Process for the preparation of easily compressible tablets from pharmaceutically active agents with poor tablet formulation characteristics |